What is the expected reduction in potassium levels for a hemodialysis (HD) patient using a K1 (potassium) bath over a 4-hour session?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Potassium Reduction in Hemodialysis with K1 Bath Over 4 Hours

A hemodialysis session using a K1 (1 mEq/L) dialysate bath over 4 hours can be expected to reduce serum potassium by approximately 1.0-1.2 mEq/L from pre-dialysis levels. 1, 2

Factors Affecting Potassium Reduction

  • The average potassium removal during a 4-hour hemodialysis session with K1 dialysate is approximately 60-80 mEq, which is significantly more effective than using higher potassium dialysate concentrations 1
  • Using K1 dialysate removes approximately 24% more potassium than K2 dialysate and 50% more than higher potassium baths 1
  • The magnitude of potassium reduction depends on several factors:
    • Pre-dialysis serum potassium level (higher initial levels typically result in greater absolute reduction) 3
    • Patient's total body potassium status 4
    • Potassium mobilization clearance (median 158 mL/min) 3
    • Central distribution volume of potassium 3

Potassium Kinetics During Hemodialysis

  • Potassium removal during hemodialysis follows a pseudo one-compartment model 3
  • Approximately 42% of removed potassium comes from the extracellular space, with the remainder mobilized from intracellular stores 4
  • Potassium mobilization clearance is independent of dialysate potassium concentration 3
  • The central distribution volume is lower at higher dialysate potassium concentrations 3

Post-Dialysis Potassium Rebound

  • Despite effective potassium removal during dialysis, a significant rebound in serum potassium occurs post-dialysis 4
  • Plasma potassium typically rebounds by 1.0-1.4 mEq/L within 6 hours after dialysis completion 4
  • This rebound occurs due to redistribution from intracellular to extracellular compartments 4
  • Patients with marked hyperkalemia should be monitored closely post-dialysis due to this rebound phenomenon 4

Safety Considerations

  • K1 dialysate is generally safe for most hemodialysis patients without history of arrhythmias or digitalis use 1
  • For patients with severe hyperkalemia (>6.5 mEq/L), K1 dialysate is associated with lower mortality compared to higher potassium baths 2
  • Caution should be exercised in patients with known cardiac issues, as rapid potassium shifts can potentially trigger arrhythmias 5
  • The optimal serum potassium range associated with greatest survival in maintenance hemodialysis patients is 4.6-5.3 mEq/L 6

Clinical Implications

  • For patients with hyperkalemia (K+ ≥5.0 mEq/L), using lower dialysate potassium concentrations may be associated with better survival 6
  • Patients with severe hyperkalemia (>6.5 mEq/L) treated with K1 dialysate show decreased in-hospital mortality or cardiac arrest compared to higher potassium baths 2
  • Monitoring for arrhythmias during and after dialysis is important, especially in patients with risk factors for cardiac complications 5

References

Research

Safety and efficacy of low-potassium dialysate.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 1989

Research

Potassium kinetics during hemodialysis.

Hemodialysis international. International Symposium on Home Hemodialysis, 2015

Research

Plasma potassium in patients with terminal renal failure during and after haemodialysis; relationship with dialytic potassium removal and total body potassium.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1997

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Serum and dialysate potassium concentrations and survival in hemodialysis patients.

Clinical journal of the American Society of Nephrology : CJASN, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.